TrialThe oncologist2020

Safety and Efficacy of Apatinib Monotherapy for Unresectable, Metastatic Esophageal Cancer: A Single-Arm, Open-Label, Phase II Study.

Li Yanwei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.